top of page
CT.jpg

IN THE STATES

CONNECTICUT

The economic footprint of the biopharmaceutical industry can be measured by traditional indicators of employment and output, and its impact on the vendors, large and small, that provide services or supplies to America's biopharmaceutical research companies. The data below illustrates jobs, economic impact and clinical trial data for the industry as a whole, and vendor/supplier data from 15 major biopharmaceutical companies regarding their business relationships and total expenditures paid to vendors in Connecticut in 2022.

CT.png

Economic
Output

$17.2B

Direct Jobs Supported by the Industry

12,445

Total Jobs Supported

51,225

State Total Vendor Relationships

1,053

State Total Vendor Spending

$970,476,804

Clinical
Trials

581

Investments at Clinical Trial Sites

$145.2M

Clinical Trial Participants

9,582

Total Economic Impact of Clinical Trial Sites

$374M

bottom of page